The FDA is deciding whether to temporarily allow the importation of chemotherapy drugs from unapproved manufacturers outside of the U.S. as the nation grapples with a shortage of key cancer drugs, a spokesperson with the agency told CNBC June 1.
Read the full post on Becker's Hospital Review - Healthcare News
